.jpg)
Longdom Conferences proudly presents the 3rd International Conference on Diabetes and Endocrinology 2026, with theme “Advancing Diabetes and Endocrine Care: Innovation, Precision Medicine, and Integrated Healthcare” scheduled to take place on December 14–15, 2026, in Dubai, UAE. This prestigious international forum brings together leading endocrinologists, diabetologists, clinicians, researchers, healthcare professionals, academicians, policymakers, and industry experts to discuss the latest advancements, research innovations, and clinical practices in diabetes and endocrine disorders.
We cordially invite you to be part of this distinguished scientific gathering in the vibrant city of Dubai, where global experts will come together to exchange knowledge, share experiences, and build lasting collaborations. Join us at this premier international platform to explore breakthroughs in diabetes and endocrinology, connect with thought leaders, and contribute to shaping the future of metabolic and endocrine healthcare on a global scale.
The 3rd International Conference on Diabetes and Endocrinology 2026, is a premier global platform dedicated to advancing excellence in diabetes care, endocrine research, clinical practice, education, and healthcare innovation. This international event brings together endocrinologists, diabetologists, physicians, clinicians, researchers, academicians, nutritionists, nurses, public health experts, healthcare administrators, and industry professionals to share knowledge, present pioneering research, and foster meaningful collaboration across the diabetes and endocrinology community.
Building on the success of its previous editions, the conference addresses current challenges and emerging opportunities in the prevention, diagnosis, and management of diabetes and endocrine disorders. The scientific program emphasizes evidence-based medicine, personalized and precision care, metabolic and hormonal health, digital health technologies, translational research, and interdisciplinary collaboration. Participants will benefit from a comprehensive agenda featuring keynote lectures, oral and poster presentations, panel discussions, workshops, and interactive networking sessions, designed to deliver an engaging and impactful learning experience.
WHY ATTEND?
- Gain insights into the latest advancements in diabetes research, endocrinology, and metabolic healthcare
- Learn from internationally renowned keynote speakers and leading endocrinologists
- Participate in scientific sessions, workshops, panel discussions, and poster presentations
- Explore evidence-based approaches in diabetes management, hormonal disorders, and patient-centered care
- Present your research on a prestigious international platform
- Network with endocrinologists, diabetologists, clinicians, researchers, and industry leaders worldwide
- Build global collaborations and multidisciplinary professional connections
- Enhance career growth, clinical expertise, and academic development
- Stay updated on emerging trends, technologies, and innovations in diabetes and endocrinology
WHO SHOULD ATTEND?
- Endocrinologists and Diabetologists
- Physicians and Clinical Specialists
- Diabetes Educators and Nutritionists
- Researchers and Scientists in Endocrinology and Metabolism
- Nurses and Allied Healthcare Professionals
- Public Health Professionals
- Healthcare Administrators and Hospital Managers
- Policy Makers and Healthcare Leaders
- Undergraduate, Postgraduate, and PhD Scholars
- Industry Professionals, Medical Device Manufacturers, and Pharmaceutical Experts
KEY HIGHLIGHTS
- High-impact keynote addresses by globally recognized experts in diabetes and endocrinology
- Comprehensive scientific program covering diabetes, endocrine disorders, metabolism, and hormonal health
- Oral and poster presentations showcasing cutting-edge research, clinical trials, and case studies
- Interactive panel discussions and hands-on workshops led by academic and industry leaders
- Strong focus on evidence-based medicine and personalized patient care
- Sessions on diabetes prevention, treatment innovations, and endocrine system disorders
- Insights into digital health, AI, telemedicine, and advanced diagnostic technologies
- Global networking opportunities with professionals from academia, clinical practice, and industry
VISA ASSISTANCE
- Cover Letter or Invitation Letter: Official confirmation of your invitation to participate in the event, required to support your visa application.
- Abstract Acceptance Letter: Verification that your submitted abstract has been formally accepted for presentation, essential for visa processing.
- Accommodation Letter (if booked): Proof of confirmed hotel or event accommodation, supporting your visa application requirements.
PARTICIPATION BENEFITS
- Academic Speaker: Present advanced research in diabetes and endocrinology, clinical studies, or innovative therapeutic approaches. Engage with international experts, foster academic collaborations, and gain global recognition.
- Student Speaker: Present student research projects, clinical studies, or preliminary findings. Gain international exposure, presentation experience, and expert feedback from leading specialists.
- Delegate: Attend high-impact sessions to stay informed about the latest developments in diabetes care, endocrine research, and metabolic health. Network with global healthcare professionals and thought leaders.
- Exhibitor: Showcase medical devices, diagnostic tools, pharmaceuticals, digital health solutions, or educational resources to a focused international audience. Strengthen brand visibility and connect with decision-makers.
- Participant: Engage in scientific discussions, knowledge exchange, and professional networking focused on diabetes and endocrine healthcare advancements.
- Poster Presenter: Present research findings, clinical case reports, or innovative healthcare solutions through interactive poster sessions. Receive constructive feedback and increase research visibility.
- Sponsor: Promote your organization while demonstrating leadership in diabetes care, endocrinology, and healthcare innovation. Gain premium branding, sponsored session opportunities, and targeted engagement.
- Young Researcher / Early-Career Professional: Highlight emerging research, develop professional skills, and connect with experienced mentors to accelerate academic and clinical career growth.
SESSION AND TRACKS :
- Diabetes Research and Evidence-Based Practice
- Pathophysiology of Diabetes and Metabolic Disorders
- Type 1 Diabetes – Mechanisms and Clinical Management
- Type 2 Diabetes – Prevention and Therapeutic Approaches
- Prediabetes and Early Intervention Strategies
- Obesity, Metabolism, and Endocrine Regulation
- Endocrine Disorders and Hormonal Imbalances
- Thyroid Disorders and Metabolic Impact
- Diabetes Complications and Comorbidity Management
- Cardiovascular and Renal Endocrinology
- Precision Medicine and Personalized Diabetes Care
- Digital Health, AI, and Diabetes Technologies
- Nutrition, Lifestyle Medicine, and Behavioral Health
- Diabetes and Endocrine Disorders in Special Populations
MARKET ANALYSIS REPORT
In 2025, the global diabetes and endocrinology market is estimated to be valued at approximately USD 1.1 trillion and is projected to reach around USD 1.9 trillion by 2032, growing at a compound annual growth rate (CAGR) of about 6.2%. This growth is fueled by factors such as increasing diabetes prevalence, expansion of insulin and non-insulin therapies, rising adoption of continuous glucose monitoring and insulin pump technologies, and growing emphasis on early diagnosis and preventive care. According to global health estimates, over 530 million adults are currently living with diabetes, a figure expected to rise significantly by 2030, intensifying the need for specialized endocrinology services and evidence-based clinical solutions.
Past Conference Report – 2024
Building on its earlier success, the Diabetes and Endocrinology Conference 2024 expanded its global reach, welcoming participants from diverse clinical, academic, and industry backgrounds. The program highlighted innovations in diabetes technologies, precision endocrinology, digital health integration, and personalized treatment strategies. Engaging keynote lectures, panel discussions, and research presentations stimulated in-depth discussions on improving patient outcomes and advancing translational research. The conference reinforced its reputation as a leading international forum for diabetes and endocrine professionals.
Past Conference Report – 2025
The Diabetes and Endocrinology Conference 2025 marked a significant milestone by showcasing cutting-edge research, advanced clinical practices, and transformative healthcare solutions. With increased participation from global experts, early-career researchers, and industry leaders, the conference emphasized innovation, AI-enabled care, metabolic disease prevention, and evidence-driven clinical decision-making. Sessions addressed critical topics such as diabetes complications, endocrine oncology, digital therapeutics, and global health equity. The 2025 edition strengthened international collaborations and reaffirmed the conference’s commitment to shaping the future of diabetes and endocrinology research and care worldwide.
